Vanguard Portfolio Management’s Damora Therapeutics, Inc. Ordinary Shares DMRA Stock Holding History

Vanguard Portfolio Management’s Portfolio DMRA Stock Details DMRA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$9.51M	Buy	+365,499	New	+$8.85M	﹤0.01%	2215

Other funds holding DMRA

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

RCP

Remedium Capital Partners Fort Lauderdale, Florida $452M AUM

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Siren LLC Greenwich, Connecticut $4.94B AUM 244.43% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

AAA

Affinity Asset Advisors New York $2.21B AUM 431.26% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Vanguard Portfolio Management's DMRA Position: Q2 2026 in Review

Vanguard Portfolio Management opened a new position in Damora Therapeutics, Inc. Ordinary Shares (DMRA) in Q2 2026: 365,499 shares worth $9.51M. The stake represents ﹤0.01% of the portfolio and ranks #2215 among its holdings.

50 funds tracked by Wall St. Rank hold DMRA as of Q2 2026.

Vanguard Portfolio Management held 365,499 shares of Damora Therapeutics, Inc. Ordinary Shares worth $9.51M as of Q2 2026.
Damora Therapeutics, Inc. Ordinary Shares was a new Vanguard Portfolio Management position in Q2 2026.
Damora Therapeutics, Inc. Ordinary Shares made up ﹤0.01% of Vanguard Portfolio Management's portfolio in Q2 2026, its #2215 holding.
50 funds tracked by Wall St. Rank held Damora Therapeutics, Inc. Ordinary Shares as of Q2 2026.

Based on Vanguard Portfolio Management's 13F filing for Q2 2026, filed 13 Aug 2026.